title: Use of in situ solid-phase adsorption in microbial natural product fermentation development.
abstract: It has been half a century since investigators first began experimenting with adding ion exchange resins during the fermentation of microbial natural products. With the development of nonionic polymeric adsorbents in the 1970s, the application of in situ product adsorption in bioprocessing has grown slowly, but steadily. To date, in situ product adsorption strategies have been used in biotransformations, plant cell culture, the production of biofuels, and selected bulk chemicals, such as butanol and lactic acid, as well as in more traditional natural product fermentation within the pharmaceutical industry. Apart from the operational gains in efficiency from the integration of fermentation and primary recovery, the addition of adsorbents during fermentation has repeatedly demonstrated the capacity to significantly increase titers by sequestering the product and preventing or mitigating degradation, feedback inhibition and/or cytotoxic effects. Adoption of in situ product adsorption has been particularly valuable in the early stages of natural product-based drug discovery programs, where quickly and cost-effectively generating multigram quantities of a lead compound can be challenging when using a wild-type strain and fermentation conditions that have not been optimized. While much of the literature involving in situ adsorption describes its application early in the drug development process, this does not imply that the potential for scale-up is limited. To date, commercial-scale processes utilizing in situ product adsorption have reached batch sizes of at least 30,000 l. Here we present examples where in situ product adsorption has been used to improve product titers or alter the ratios among biosynthetically related natural products, examine some of the relevant variables to consider, and discuss the mechanisms by which in situ adsorption may impact the biosynthesis of microbial natural products.
authors.affiliation: AMRI Global Fermentation and Biocatalysis, Chemical Development, 21 Corporate Circle, Albany, NY 12203, USA.
authors.forename: Thomas
authors.initials: T
authors.lastname: Phillips
authors.forename: Matthew
authors.initials: M
authors.lastname: Chase
authors.forename: Stephanie
authors.initials: S
authors.lastname: Wagner
authors.forename: Chris
authors.initials: C
authors.lastname: Renzi
authors.forename: Marcella
authors.initials: M
authors.lastname: Powell
authors.forename: Joseph
authors.initials: J
authors.lastname: DeAngelo
authors.forename: Peter
authors.initials: P
authors.lastname: Michels
mesh_terms: D000327:Adsorption; D001688:Biological Products / Q000737:chemistry / Q000302:isolation & purification* / Q000378:metabolism* / Q000633:toxicity; D019149:Bioreactors; D025461:Feedback, Physiological; D005285:Fermentation; D011108:Polymers / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D012117:Resins, Synthetic / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D013997:Time Factors
chemical_list: D001688:Biological Products; D011108:Polymers; D012117:Resins, Synthetic